ARCHIVES

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

Hatch Hearing Turns Up Few New Deficiencies In NCI Contract Management; DeVita Blasted On Strauss

June 5, 1981

Final Issue Of 1984

December 13, 1984

Excerpts Presented From Pepper Hearing

July 20, 1979

DCT Board Okays $3 Million In New Programs, $8 Million In Recompetitions

October 24, 1980

Statistical Models Determine Stem-Cell Transplant Effectiveness

July 26, 2013